| TGA Action ID |
RC-2025-RN-00969-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
Anti-GBM. An in vitro diagnostic medical device (IVD).
Product Code: ORG 550
Batch Number: 2502555
UDI: 04260157080553
Expiry Date: 28.09.2026 |
| ARTG Number |
197247 |
| Unique Device Identifier (UDI) |
04260157080553 |
| Action Type |
Product Correction |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
A customer has reported a high number of non-plausible low positive results obtained with Anti-GBM (ORG 550) lot #2502555. The outcome of an internal evaluation by the manufacturer has showed a clinical specificity of 86.0% instead of 99.3% as claimed in the IFU.
Due to the reduced specificity of the product, there is a possibility of false positive results. False elevated or false positive anti-GBM results may lead the doctor to assume that the patient has anti-GBM disease mistakenly. This may lead to inappropriate therapy with glucocorticosteroids, cyclophosphamide or plasma exchange. Due to immunosuppression, potential adverse events especially include serious and opportunistic infections. Furthermore, plasmapheresis itself can cause side effects related to the procedure of central vascular access, as well as hypotension, thrombosis and infections.
Batch 2502555 has been distributed to hospitals and pathology laboratories since 22 September 2025. |
| Instructions for Customers/Users |
If customers have affected product they should: · Review patient results that have been already obtained with the affected lot to identify if positive results could be affected by the describedproblem. · In case of positive results (>20 U/ml): Confirm the positive Anti-GBM results obtained with the affected ORGENTEC kit lot number using an alternative method. If users have no access to an alternative method, they should contact their local distributor. · Negative results (<20 U/ml) are not affected by the described problem and can be reported as usual. · The use of the affected kit lot can be continued as described in the instruction for use (IFU) and following the afore described recommendations.
This action has been closed out on 08/04/2026 |
| Action Commencement Date |
17/11/2025 |
| Responsible Entity |
|
| Contact Information |
02 9666 7776 - Southern Cross Diagnostics |